GL1X · GenesisL1 explorer

MolNFT v1 · #112681 · protein

Bace crystal structure with bicyclic aminothiazine inhibitor

4ZSP · Beta-secretase 1: “Bace crystal structure with bicyclic aminothiazine inhibitor”. X-ray diffraction, 1 ligand (4RZ), 5 pockets (best druggability 0.70). MolNFT v1 #112681 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
4ZSP
Type
protein
Length
779 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Beta-secretase 1
EC
3.4.23.46
UniProt
P56817
Ligands
4RZ
Pockets
5 · best druggability 0.70

Structure

x-ray diffraction · 2 distinct chains · 16% helix, 39% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABeta-secretase 1 (EC 3.4.23.46)protein39016% helix, 39% strandP56817
BBeta-secretase 1 (EC 3.4.23.46)protein38916% helix, 39% strandP56817

Ligands and binding sites

  • 4RZ · N-[(4aS,6S,8aR)-2-amino-4a,5,6,7,8,8a-hexahydro-4H-3,1-benzothiazin-6-yl]-3-chlorobenzamide · ligand · 2 copies · chains A, B
  • GOL · Glycerol · additive · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 5 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14520.700.8150GOL
25090.670.78404RZ
33300.650.8137empty
44800.650.77414RZ
5890.560.8629empty

Interfaces

1 interface between chains.

  • A–B · 514 Ų buried · 2 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 6 disulfide (disulfide).

Compared structures

  • 4ZSP · BACE crystal structure with bicyclic aminothiazine inhibitor · the same entry in another collection · chain A against A, TM-score 1.00
  • P56817 · AlphaFold monomer V2.0 prediction for beta-secretase 1 (P56817) · a predicted model of the same protein · chain B against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.